The Australian Therapeutic Goods Association (TGA) regularly issues safety alerts about counterfeit medicines that may have been unknowingly purchased by consumers via the internet or overseas.

At Lilly, patient safety is our number one priority. Counterfeit medicines pose serious public health risks as they are manufactured illegally, often in unsanitary conditions. Counterfeit medicines often contain high levels of impurities and contaminants which are harmful and potentially fatal, including arsenic, boric acid, brick dust, cement powder, chalk dust, floor polish, leaded road paint, nickel, shoe polish and talc and may contain no active pharmaceutical ingredient or not the one described.

Lilly is committed to helping combat pharmaceutical counterfeiting. Our global Anti-Counterfeiting efforts are an important component of our concern for public health. Patients are urged to exercise extreme caution when purchasing any pharmaceutical medicine, particularly those that require a prescription from a doctor in Australia. Online or overseas-sourced products may not meet the same high standards of quality, safety and efficacy as those approved by the TGA for supply in Australia.

If you or your patients are in possession of any Lilly medicine that you suspect could be counterfeit, call Lilly Medical Information immediately on: 1800 4 LILLY (1800 454 559) or take the products to your local pharmacist for safe disposal.

If you are a patient and have any concerns about any pharmaceutical product you have taken, consult your healthcare practitioner immediately.